Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture

Frontiers in Microbiology
Daniela S Rajão, Daniel R Pérez

Abstract

Influenza virus infections pose a significant threat to public health due to annual seasonal epidemics and occasional pandemics. Influenza is also associated with significant economic losses in animal production. The most effective way to prevent influenza infections is through vaccination. Current vaccine programs rely heavily on the vaccine's ability to stimulate neutralizing antibody responses to the hemagglutinin (HA) protein. One of the biggest challenges to an effective vaccination program lies on the fact that influenza viruses are ever-changing, leading to antigenic drift that results in escape from earlier immune responses. Efforts toward overcoming these challenges aim at improving the strength and/or breadth of the immune response. Novel vaccine technologies, the so-called universal vaccines, focus on stimulating better cross-protection against many or all influenza strains. However, vaccine platforms or manufacturing technologies being tested to improve vaccine efficacy are heterogeneous between different species and/or either tailored for epidemic or pandemic influenza. Here, we discuss current vaccines to protect humans and animals against influenza, highlighting challenges faced to effective and uniform novel vac...Continue Reading

References

Feb 1, 1987·The Journal of Experimental Medicine·F GotchB Moss
Sep 1, 1966·The Journal of Experimental Medicine· Fazekas de St Groth, R G Webster
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·G NeumannY Kawaoka
May 10, 2000·Proceedings of the National Academy of Sciences of the United States of America·E HoffmannR G Webster
Dec 14, 2006·The Journal of Infectious Diseases·William W ThompsonDavid K Shay
Nov 23, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·K J Holm, K L Goa
Nov 28, 2007·Annual Review of Pathology·Jeffery K Taubenberger, David M Morens
Feb 12, 2008·The Journal of Infectious Diseases·David I BernsteinHeather Hill
Feb 22, 2008·Journal of Virology·Heui Man KimSang Heui Seo
Sep 5, 2008·Journal of Virology·Rong HaiPeter Palese
Sep 11, 2008·Nature Reviews. Genetics·Michele A Kutzler, David B Weiner
Mar 3, 2009·Science·Damian C EkiertIan A Wilson
May 20, 2009·Vaccine·Christian HerzogReinhard Glück
Jul 22, 2009·Revue Scientifique Et Technique·J K Taubenberger, D M Morens
Sep 22, 2009·Current Topics in Microbiology and Immunology·Jüergen A Richt, Adolfo García-Sastre
Nov 18, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michelle D TatePatrick C Reading
Apr 30, 2010·Animal Health Research Reviews·E Paul J Gibbs, Tara C Anderson
Dec 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karim El BakkouriXavier Saelens

❮ Previous
Next ❯

Citations

Apr 9, 2019·Expert Opinion on Biological Therapy·Cecilia TrucchiFilippo Ansaldi
Jul 3, 2019·Expert Review of Vaccines·Claudia Maria TrombettaEmanuele Montomoli
Sep 25, 2019·Proceedings of the National Academy of Sciences of the United States of America·Pratha SahAlison P Galvani
Nov 7, 2019·Vaccines·Seyed Davoud Jazayeri, Chit Laa Poh
Dec 13, 2019·Expert Review of Vaccines·Laurent DurousEmma Petiot
May 16, 2020·Human Vaccines & Immunotherapeutics·Ying XiaShenghui Qin
Jul 12, 2020·Transboundary and Emerging Diseases·Fabian O Chamba PardoMontserrat Torremorell
Sep 27, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Natalya Sh LebedevaOskar I Koifman
Sep 9, 2020·Journal of Leukocyte Biology·Mitchell KlompM Nadeem Khan
Aug 6, 2019·Frontiers in Immunology·Cynthia Calzas, Christophe Chevalier
Feb 23, 2020·Science·Susanne Herold, Leif-Erik Sander
Apr 10, 2018·Frontiers in Immunology·Arun KumarSylvie Bertholet
May 26, 2018·Vaccines·Sarah Sebastian, Teresa Lambe
Jan 30, 2019·Nature Medicine·Seiya Yamayoshi, Yoshihiro Kawaoka
Jul 18, 2018·Frontiers in Immunology·Sophie A ValkenburgBenjamin J Cowling
Feb 8, 2019·BMC Infectious Diseases·Michaela E Nickol, Jason Kindrachuk
Dec 24, 2018·Frontiers in Veterinary Science·Efrain Guzman, Maria Montoya
Mar 1, 2019·Viruses·Pilar Blanco-LoboLuis Martínez-Sobrido
Jun 6, 2019·Beilstein Journal of Nanotechnology·Zaid K AlghrairBahram Ebrahimi
Oct 24, 2019·Journal of Biomedical Science·Jiun-Jie Shie, Jim-Min Fang
Feb 16, 2020·Nature Reviews. Drug Discovery·Chih-Jen WeiGary J Nabel
Sep 27, 2018·Frontiers in Immunology·Sophia Davidson
Oct 25, 2020·Sensors·Sheng-Yu TsaiChing-Wei Cheng
Jan 14, 2021·Vaccines·Marie-Eve Laliberté-GagnéDenis Leclerc
Nov 25, 2020·Vaccines·Nathaniel Nyakaat NinyioAbdul Razak Mariatulqabtiah
Mar 3, 2021·Porcine Health Management·Hamish A Salvesen, C Bruce A Whitelaw

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA
ELISA

Software Mentioned

MacPymol

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved